Business Daily from THE HINDU group of publications
Thursday, Oct 12, 2006
ePaper


News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate - Regulatory Bodies & Rulings
Aurobindo gets FDA nod for AIDS drug

Our Bureau

Hyderabad , Oct. 11

Aurobindo Pharma Ltd has announced that the United Sates Food and Drug Administration (USFDA) has granted tentative approval for the company's Didanosine Oral Suspension (paediatric powder) 10 mg/ml.

The drug is indicated for use in paediatric patients with HIV. Didanosine is active against the human immunodeficiency virus (HIV) that causes AIDS.

It is in the class of drugs called nucleoside reverse transcriptase inhibitors (NRTIs), which helps keep the AIDS virus from reproducing. The drug is used in combination with other antiretroviral agents for the treatment of HIV-1 infection.

In a press release here on Tuesday, the company said this product is the first generic version of the research product, Videx paediatric powder for Oral Suspension, 10-mg/ml, manufactured by Bristol Myers Squibb Pharmaceuticals.

Aurobindo Pharma said the product would now be available for consideration for purchase under the US President's Emergency Programme for AIDS Relief (PEPFAR). The company said it manufactures both active pharmaceutical ingredient (API) and formulation for this generic.

With this approval, Aurobindo Pharma now has 32 products approved by USFDA (inclusive of tentative approvals) and 17 of them are anti-retrovirals (ARVs).

More Stories on : Regulatory Bodies & Rulings | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Dunlop spends Rs 150 cr in modernisation of plants


Trent plans preferential, rights issues
Claris Life Sciences plans to launch cancer drugs by year-end
Hinduja TMT to pump Rs 500 cr in arm
Madhucon's TN project closure
Cooper Ind, Patton sign pact
Reservations about quotas for women on boards
Merger is an option in Tata Steel-Corus talks
Maharashtra, Dempo Group sign pact
`Singapore ideal pick to set up production'
Aurobindo gets FDA nod for AIDS drug
Shareholders' pact signed for rail SPV
Parikh Associates plans to invest Rs 60 cr in Sahil Group
NEPC plans to diversify
Essar drilling apace in Ranigunj block


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line